Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Atkins

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
BMC Genomics|May 21, 2011
BAC library resources for map-based cloning and physical map construction in barley (Hordeum vulgare L.)Daniela Schulte, Ruvini Ariyadasa, Bujun Shi, et al.
Immunotherapy|December 20, 2018
Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanomaAhmad Tarhini, David McDermott, Apoorva Ambavane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II studySanjiv S Agarwala, John M Kirkwood, Martin Gore, et al.
Developmental Biology|January 23, 2016
A Notch-Gli2 axis sustains Hedgehog responsiveness of neural progenitors and Müller gliaRandy Ringuette, Michael Atkins, Pamela S Lagali, et al.
Clinical Genitourinary Cancer|October 25, 2007
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinomaDaniel Cho, Sabina Signoretti, Sandra Dabora, et al.
Immunotherapy|September 4, 2018
Sequential treatment approaches in  the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysisAhmad Tarhini, Agnes Benedict, David McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology GroupRobert Gray, Judith Manola, Scott Saxman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2011
Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working groupJudith Manola, Patrick Royston, Paul Elson, et al.
Cancers|November 9, 2024
PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid CancerLeila Shobab, Deema Al-Souri, Liza Mathews-Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responsesDavid Avigan, Baldev Vasir, Jianlin Gong, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
BMC Genomics|May 21, 2011
BAC library resources for map-based cloning and physical map construction in barley (Hordeum vulgare L.)Daniela Schulte, Ruvini Ariyadasa, Bujun Shi, et al.
Immunotherapy|December 20, 2018
Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanomaAhmad Tarhini, David McDermott, Apoorva Ambavane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II studySanjiv S Agarwala, John M Kirkwood, Martin Gore, et al.
Developmental Biology|January 23, 2016
A Notch-Gli2 axis sustains Hedgehog responsiveness of neural progenitors and Müller gliaRandy Ringuette, Michael Atkins, Pamela S Lagali, et al.
Clinical Genitourinary Cancer|October 25, 2007
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinomaDaniel Cho, Sabina Signoretti, Sandra Dabora, et al.
Immunotherapy|September 4, 2018
Sequential treatment approaches in  the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysisAhmad Tarhini, Agnes Benedict, David McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology GroupRobert Gray, Judith Manola, Scott Saxman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2011
Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working groupJudith Manola, Patrick Royston, Paul Elson, et al.
Cancers|November 9, 2024
PD-L1 Expression Varies in Thyroid Cancer Types and Is Associated with Decreased Progression Free Survival (PFS) in Patients with Anaplastic Thyroid CancerLeila Shobab, Deema Al-Souri, Liza Mathews-Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responsesDavid Avigan, Baldev Vasir, Jianlin Gong, et al.
Pageof 6